Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BRCA1 in special populations.

J P Struewing1

  • 1Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7372, USA. struewing@nih.gov

Breast Disease
|February 3, 2005
PubMed
Summary

Specific BRCA1 gene mutations are common in Ashkenazi Jewish individuals. These mutations increase risks for breast, ovarian, and prostate cancers, aiding research into cancer risk factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skewed X chromosome inactivation and early-onset breast cancer.

Journal of medical genetics·2005
Same author

Prospective risk of cancer in CDKN2A germline mutation carriers.

Journal of medical genetics·2004
Same author

XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk.

British journal of cancer·2004
Same author

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.

Journal of medical genetics·2003
Same author

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.

Gynecologic oncology·2003
Same author

Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women.

Gynecologic oncology·2002

Area of Science:

  • Genetics and Hereditary Cancer Research
  • Population Genetics
  • Cancer Epidemiology

Background:

  • Specific BRCA1 gene mutations (185delAG, 5382insC, 188del11) are prevalent in the Ashkenazi Jewish population.
  • These mutations are significant contributors to hereditary cancer risk.
  • Understanding their impact is crucial for genetic counseling and risk assessment.

Purpose of the Study:

  • To re-estimate the penetrance of abnormal BRCA1 alleles in the Ashkenazi Jewish population.
  • To investigate the association between BRCA1 mutations and other cancer types, specifically prostate and colorectal cancers.
  • To identify potential cofactors modifying BRCA1-associated cancer risk.

Main Methods:

  • Analysis of BRCA1 mutation frequencies in the Ashkenazi Jewish population.
  • Calculation of cancer penetrance for breast and ovarian cancers based on mutation data.
  • Comparative analysis of cancer incidence (prostate, colorectal) in BRCA1 carriers versus non-carriers.

Main Results:

  • BRCA1 allele penetrance estimated at 50-60% for breast cancer and 8-16% for ovarian cancer.
  • A statistically significant increase in prostate cancer rates was observed in BRCA1 carriers.
  • No increased rate of colorectal cancer was found in BRCA1 carriers.

Conclusions:

  • The study provides updated penetrance estimates for BRCA1 mutations in a specific population.
  • BRCA1 mutations are associated with increased risk for prostate cancer, expanding the known cancer spectrum.
  • The Ashkenazi Jewish population serves as a valuable model for identifying genetic or environmental factors influencing BRCA1 cancer risk.

Related Experiment Videos